Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia

被引：0
作者：
Moujaber, Tania
Tran Ben
Liow, Elizabeth
Clay, Timothy
Bennett, Geer
Kearney, Mairead
Gibberd, Alison
Gurney, Howard
机构：
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs68
引用
收藏
页码：94 / 95
页数：2
相关论文
共 50 条
  • [21] Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).
    Barthelemy, Philippe
    Loriot, Yohann
    Voog, Eric
    Eymard, Jean Christophe
    Ravaud, Alain
    Flechon, Aude
    Jaillon, Christine Abraham
    Chasseray, Matthieu
    Lorgis, Veronique
    Hilgers, Werner
    Gobert, AurElien
    Le Moulec, Sylvestre
    Simon, Camille
    Nicolas, Emanuel
    Escande, Anne
    Pouessel, Damien
    Josse, Constant
    Solbes, Marie-Noelle
    Lambert, Prisca
    Thibault, Constance
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [22] Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US.
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie A.
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Rey, Gabriel Gomez
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 605 - 605
  • [23] Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
    Morgans, Alicia K.
    Galsky, Matthew D.
    Wright, Phoebe
    Hepp, Zsolt
    Chang, Nancy
    Willmon, Candice L.
    Sesterhenn, Steve
    Liu, Yutong
    Sonpavde, Guru P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) : 357e11 - 357e21
  • [24] Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice
    Grivas, Petros
    Agarwal, Neeraj
    Pal, Sumanta
    Kalebasty, Arash Rezazadeh
    Sridhar, Srikala S.
    Smith, Jodi
    Devgan, Geeta
    Sternberg, Cora N.
    Bellmunt, Joaquim
    CANCER TREATMENT REVIEWS, 2021, 97
  • [25] Audit of Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma Treated in the Early Access Scheme
    Renninson, E.
    Sonker, P.
    Challapalli, A.
    Hudson, Z.
    Hilman, S.
    Bahl, A.
    CLINICAL ONCOLOGY, 2023, 35 (02) : E241 - E242
  • [26] Real-world prescribing patterns for first-line and maintenance treatment of patients with advanced urothelial cancer (UC)
    Inderjeeth, Andrisha-Jade
    O'haire, Sophie
    Gibbs, Peter
    Wong, Lih-Ming
    Zhang, Alison
    Manohar, Paul
    James, Lynam
    Sengupta, Shomik
    Wong, Shirley
    Weickhardt, Andrew
    Tran, Ben
    Conduit, Ciara
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 95 - 95
  • [27] US real-world first-line (1L) treatment patterns and outcomes for patients with metastatic urothelial carcinoma (mUC) following maintenance avelumab approval.
    Li, Haojie
    Herms, Lisa
    Leong, Traci
    Conkling, Paul R.
    Franco, Sonia
    Singhal, Puneet
    Mamtani, Ronac
    Bupathi, Manojkumar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [28] Avelumab first-line maintenance for advanced or metastatic urothelial carcinoma: analysis from JAVELIN Bladder 100 trial
    Madiraju, Srigita
    Petros, Firas G.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2024, 13 (07) : 1327 - 1328
  • [29] Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment
    Barthelemy, Philippe
    Thibault, Constance
    Flechon, Aude
    Gross-Goupil, Marine
    Voog, Eric
    Eymard, Jean-Christophe
    Abraham, Christine
    Chasseray, Matthieu
    Lorgis, Veronique
    Hilgers, Werner
    Gobert, Aurelien
    Le Moulec, Sylvestre
    Simon, Camille
    Nicolas, Emanuel
    Escande, Anne
    Pouessel, Damien
    Mouillet, Guillaume
    Josse, Constant
    Solbes, Marie-Noelle
    Lambert, Prisca
    Loriot, Yohann
    EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (02): : 407 - 416
  • [30] Avelumab first-line maintenance (1LM) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Czech Republic: Interim real-world results from a national reimbursement registry.
    Zemankova, Anezka
    Studentova, Hana
    Melichar, Bohuslav
    Eid, Michal
    Poprach, Alexandr
    Kopecky, Jindrich
    Spacek, Jan
    Stuhlova, Sarka
    Dvorak, Jan
    Vlcek, Pavel
    Zychackova, Katerina
    Katolicka, Jana
    Blazek, Tomas
    Vrana, David
    Majkova, Petra
    Cepa, Adam
    Fiala, Ondrej
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 557 - 557
12345